Search

Yu P Bai

from Flushing, NY
Age ~61
Get Report
Also known as:
Ping Bai Yu, Yuping Bai
Phone and address:
4202 Forley St, Flushing, NY 11373
(718) 565-8896
Related to:
Wei Wei Yu, 62Yu Ding, 62Ying Yeh Yu, 57Yun Ding, 52Te Lin Yu, 68Yong P Yu, 56Yu Li, 52Ding Yun, 52Dorothea S Wong, 85
Connected to:
Aaron C Bai, 55Angela Y Bai, 29Bill B Bai, 36Cindy Bai, 57Dong Bai, 68Eddie Z Bai, 80Esther Y Bai, 56Henry Bai, 84Houwu Bai, 49Hu Y Bai, 65

Yu Bai Phones & Addresses

  • 4202 Forley St, Elmhurst, NY 11373 (718) 565-8896
  • Flushing, NY

Professional Records

License Records

Yu Z Bai

Address:
1165 Macgregor West Ave, Worthington, OH
132 70 Sanford Ave, Flushing, NY
Phone:
(614) 781-6142
License #:
50937 - Expired
Category:
Health Care
Issued Date:
Jul 30, 2007
Effective Date:
Jun 4, 2014
Expiration Date:
Aug 31, 2013
Type:
Massage Therapist

Medicine Doctors

Yu Bai Photo 1

Yu Bai

View page
Specialties:
Clinical Pathology, Hematology
Work:
University Of Texas Health Science Center Pathology & Laboratory Medicine
6431 Fannin St STE 2.020, Houston, TX 77030
(855) 488-7284 (phone), (713) 500-0731 (fax)
Education:
Medical School
Beijing Med Univ, Beijing City, Beijing, China
Graduated: 1987
Languages:
English
Description:
Dr. Bai graduated from the Beijing Med Univ, Beijing City, Beijing, China in 1987. She works in Houston, TX and specializes in Clinical Pathology and Hematology. Dr. Bai is affiliated with UT Health Northeast.

Resumes

Resumes

Yu Bai Photo 2

Staff Scientist In Bioinformatics At Regeneron Pharmaceuticals

View page
Position:
Staff Scientist, Bioinformatics at Regeneron Pharmaceuticals
Location:
Greater New York City Area
Industry:
Pharmaceuticals
Work:
Regeneron Pharmaceuticals since Jan 2013
Staff Scientist, Bioinformatics
Regeneron Pharmaceuticals Apr 2010 - Dec 2012
Scientist, Bioinformatics
Seralogix Inc. Oct 2008 - Mar 2010
Sr. Scientist for Bioinformatics and Modeling
WM Keck Center for Computational & Structural Biology 2007 - 2008
Postdoc (Keck Fellow)
SRI International Jul 2005 - Sep 2005
Summer Research Intern
Education:
Stanford University 2002 - 2007
University of Science and Technology of China
Skills:
Bioinformatics
Data Mining
Genomics
Systems Biology
Pattern Recognition
Computational genomics
Machine Learning
relational database
Bayesian networks
Multivariate Statistics
Monte Carlo Simulation
Dynamic Simulation
Honor & Awards:
- Phase I SBIR grant awarded by National Institute of Alergies and infectious Desease -WM Keck Nanobiology Postdoctoral Fellowship (NIH) -Best Student Research Paper Award by IEEE Bioinformatics and Bioengineering -Stanford Graduate Fellowship
Languages:
French(basic)
Awards:
Selected Publications
- "Relationship network based on consensus clustering:a powerful tool to dissect complex biology signatures" (2013) Y.Bai, W. Fury, in prep - "Identify potential genetic risks underlying congenital myopathy and cardiac defects using exome and whole genome sequencing" (2012), Y.Bai, Y. Huang, Z.Y. Wang et al, CLARITY challenge submission, Boston Children's Hospital - "Comparison of the effects of aflibercept (VEGF Trap) and small molecule kinase inhibitors on tumors and normal organs in mouse models" (2012) E. Ioffe, E. Burova, S. Nandor, Y. Bai, J. S. Rudge, and G. Thurston Cancer Research, 72, 1158 - "BioSignature Discovery System (BiosignatureDS™): a next generation solution for OMICS analysis and modeling in drug discovery and personalized medicine" Y. Bai, D.C. Willey, KL Drake, et al (2011) White paper, Seralogix Inc - "Enhancing the role of veterinary vaccines reducing zoonotic diseases of humans: linking systems biology with vaccine development" LG Adams, S Khare, SD Lawhon, CA Rossetti, HA Lewin, MS Lipton, JE Turse, DC Wylie, Y Bai, KL Drake, (2011) Vaccine, 29, 7197 - Y. Bai, M.Tong (2011) Biophys. J. 100(3) pp. 321a - 322a - Y. Bai (2010) Biophys. J. 98(3) pp. 197a - Y. Bai, V. Chu, J. Lipfert, V. Pande, D. Herschlag, S. Doniach (2008) JACS, 130, 12334 - A. Abate*, Y. Bai*, C. Talcott, A. Tiwari (2007) Proceedings of IEEE 7th ISBB, pp. 922 - Y. Bai, M. Greenfeld, K. J. Travers, V. B. Chu, J. Lipfert, S. Doniach, D. Herschlag (2007), JACS, 129, 14981 - Y. Bai, R. Das, I.S. Millett, D. Herschlag, S. Doniach(2005) PNAS 102, 1035
Yu Bai Photo 3

Yu Bai

View page
Yu Bai Photo 4

Yu Bai

View page
Yu Bai Photo 5

Yu Bai

View page
Yu Bai Photo 6

Yu Bai

View page
Yu Bai Photo 7

Yu Bai

View page
Location:
United States
Yu Bai Photo 8

Yu Bai

View page
Location:
United States
Yu Bai Photo 9

Researcher At Xi'an Jiaotong University Suzhou Institute

View page
Position:
Researcher at Xi'an Jiaotong University Suzhou Institute
Location:
Suzhou, Jiangsu, China
Industry:
Nanotechnology
Work:
Xi'an Jiaotong University Suzhou Institute - Suzhou Industrial Park, Suzhou, China since Sep 2011
Researcher
MIT Sep 2004 - Jun 2011
Graduate Student Research Assistant
North American Chinese Semiconductor Association, Boston Chapter Sep 2006 - Sep 2008
Founder and co-president
Semiconductor Manufacturing International Corporation Aug 2003 - Aug 2004
Senior Associate Engineer, Technology Development Center
Institute of Materials Research and Engineering - Singapore Jan 2003 - Jun 2003
Research Internship
Education:
Massachusetts Institute of Technology 2004 - 2011
Ph.D, Department of Materials Science and Engineering National University of Singapore 2002 - 2003
Master of Science, Advanced Materials for Micro and Nano electronic systems Xi'an Jiaotong University 1998 - 2002
Bachelor of Engineering, Materials Science and Engineering - Advanced ceramics and surface Science
Skills:
Materials
Thin Films
Electronics
Solar
Epitaxy
Interests:
Technology Innovation and Entrepreneurship Integrated circuits, Micro/Nano electronic systems, Technology for Renewable Energy and sustainability Science Education
Honor & Awards:
MIT Solar Revolution Project Fellowship; Outstanding Engineering, SMIC (2004); Singapore-MIT Alliance Fellowship (2003);
Languages:
Chinese
English

Business Records

Name / Title
Company / Classification
Phones & Addresses
Yu Bai
Chief Executive Officer, Executive Director
IVY NAILS, INC
Beauty Shop
889 Hempstead Tpke, Franklin Square, NY 11010
139-19 34 Rd APT #3C, Flushing, NY 11354
(516) 326-0733

Publications

Us Patents

Accurate And Robust Information-Deconvolution From Bulk Tissue Transcriptomes

View page
US Patent:
20210142867, May 13, 2021
Filed:
Nov 6, 2020
Appl. No.:
17/091484
Inventors:
- Tarrytown NY, US
Yu Bai - Tarrytown NY, US
Wen Fury - Tarrytown NY, US
Gurinder Atwal - Tarrytown NY, US
International Classification:
G16B 30/00
G16B 5/00
Abstract:
This disclosure relates to methods for deconvolving bulk or spatial RNA-sequencing data, computer readable medium storing processor-executable instructions adapted to deconvolve bulk or spatial RNA-sequencing data, and systems for deconvolving bulk or spatial RNA-sequencing data to characterize cell type compositions.

Production Of Fertile Xy Female Animals By Silencing Of Genes On The Y Chromosome

View page
US Patent:
20210112788, Apr 22, 2021
Filed:
Dec 11, 2020
Appl. No.:
17/119076
Inventors:
- Tarrytown NY, US
David Frendewey - New York NY, US
Junko Kuno - Holmes NY, US
Chia-Jen Siao - New York NY, US
Gustavo Droguett - New City NY, US
Yu Bai - Scarsdale NY, US
Wojtek Auerbach - Ridgewood NJ, US
Assignee:
Regeneron Pharmaceuticals, Inc. - Tarrytown NY
International Classification:
A01K 67/027
C12N 5/0735
C12Q 1/6876
G01N 33/50
Abstract:
Methods and compositions are provided for generating F0 fertile XY female animals. The methods and compositions involve making XY pluripotent or totipotent animal cells, in vitro cell cultures, or embryos that are capable of producing a fertile female XY animal in an F0 generation. Such cells, embryos, and animals can be made by silencing a region of the Y chromosome. Optionally, the cells can also be cultured in feminizing medium such as a low-osmolality medium and/or can be modified to decrease the level and/or activity of an Sry protein. Methods and compositions are also provided for silencing a region of the Y chromosome in an XY pluripotent or totipotent animal cell, or in vitro cell cultures, embryos, or animals derived therefrom, by maintaining an XY pluripotent or totipotent animal cell in a feminizing medium. Methods and compositions are also provided for maintaining a population of XY pluripotent or totipotent animal cells in a feminizing medium and selecting cells or clones having increased capabilities for producing a fertile female XY animal in an F0 generation. Methods and compositions are also provided for screening for compounds with feminizing activity or for optimizing concentrations of components in feminizing media.

Methods And Systems For Crispr Selection

View page
US Patent:
20200299679, Sep 24, 2020
Filed:
Mar 17, 2020
Appl. No.:
16/821607
Inventors:
- Tarrytown NY, US
Yu Bai - Tarrytown NY, US
International Classification:
C12N 15/10
C12Q 1/6874
G01N 33/50
G16B 20/00
G16B 30/00
Abstract:
Methods and systems for CRISPR positive selection are described. CRISPR positive selection uses DNA sequencing to identify genes that their perturbation by CRISPR guide RNAs is correlated to the phenotype.

Crispr/Cas Dropout Screening Platform To Reveal Genetic Vulnerabilities Associated With Tau Aggregation

View page
US Patent:
20200299681, Sep 24, 2020
Filed:
Mar 17, 2020
Appl. No.:
16/821384
Inventors:
- Tarrytown NY, US
Matthew Koss - Mount Kisco NY, US
Yu Bai - Scarsdale NY, US
Brian Zambrowicz - Sleepy Hollow NY, US
International Classification:
C12N 15/10
C12N 15/113
C12N 9/22
Abstract:
Cas-protein-ready tau bio sensor cells, CRISPR/Cas synergistic activation mediator (SAM)-ready tau biosensor cells, and methods of making and using such cells to screen for genetic vulnerability associated with tau aggregation are provided.

Biomarkers Related To Interleukin-33 (Il-33)-Mediated Diseases And Uses Thereof

View page
US Patent:
20180258164, Sep 13, 2018
Filed:
May 21, 2018
Appl. No.:
15/985660
Inventors:
- Tarrytown NY, US
Jeanne Allinne - New York NY, US
Wen Fury - New York NY, US
Yu Bai - Scarsdale NY, US
International Classification:
C07K 16/24
A61K 39/395
A61K 45/06
A61K 38/17
C07K 14/575
G01N 33/68
A61K 39/00
Abstract:
The present invention relates to the identification of certain biomarkers for use in identifying patients who have, or are likely to develop an IL-33 mediated disease or disorder and who are more likely to respond to therapy with an IL-33 antagonist. The invention also relates to methods of treatment of an IL-33-mediated disease or disorder in a patient by administering an IL-33 antagonist to the patient in need thereof and monitoring the effectiveness of therapy using the biomarkers described herein. Also provided are methods for decreasing the level of at least one biomarker in a subject suffering from an IL-33-mediated disease or disorder, and methods for treating such diseases or disorders according to the expression levels of one or more biomarkers. The methods of the present invention comprise administering to a subject in need thereof a pharmaceutical composition comprising an interleukin-33 antagonist.

Biomarkers Related To Interleukin-33 (Il-33)-Mediated Diseases And Uses Thereof

View page
US Patent:
20170096483, Apr 6, 2017
Filed:
Oct 5, 2016
Appl. No.:
15/285772
Inventors:
- Tarrytown NY, US
Jeanne Allinne - New York NY, US
Wen Fury - New York NY, US
Yu Bai - Scarsdale NY, US
International Classification:
C07K 16/24
A61K 38/17
A61K 45/06
C07K 14/715
G01N 33/68
A61K 39/395
Abstract:
The present invention relates to the identification of certain biomarkers for use in identifying patients who have, or are likely to develop an IL-33 mediated disease or disorder and who are more likely to respond to therapy with an IL-33 antagonist. The invention also relates to methods of treatment of an IL-33-mediated disease or disorder in a patient by administering an IL-33 antagonist to the patient in need thereof and monitoring the effectiveness of therapy using the biomarkers described herein. Also provided are methods for decreasing the level of at least one biomarker in a subject suffering from an IL-33-mediated disease or disorder, and methods for treating such diseases or disorders according to the expression levels of one or more biomarkers. The methods of the present invention comprise administering to a subject in need thereof a pharmaceutical composition comprising an interleukin-33 antagonist.

Production Of Fertile Xy Female Animals By Silencing Of Genes On The Y Chromosome

View page
US Patent:
20170079250, Mar 23, 2017
Filed:
Sep 16, 2016
Appl. No.:
15/268452
Inventors:
- Tarrytown NY, US
David Frendewey - New York NY, US
Junko Kuno - Holmes NY, US
Chia-Jen Siao - New York NY, US
Gustavo Droguett - New City NY, US
Yu Bai - Scarsdale NY, US
Wojtek Auerbach - Ridgewood NJ, US
International Classification:
A01K 67/027
C12N 5/0735
G01N 33/50
C12Q 1/68
Abstract:
Methods and compositions are provided for generating F0 fertile XY female animals. The methods and compositions involve making XY pluripotent or totipotent animal cells, in vitro cell cultures, or embryos that are capable of producing a fertile female XY animal in an F0 generation. Such cells, embryos, and animals can be made by silencing a region of the Y chromosome. Optionally, the cells can also be cultured in feminizing medium such as a low-osmolality medium and/or can be modified to decrease the level and/or activity of an Sry protein. Methods and compositions are also provided for silencing a region of the Y chromosome in an XY pluripotent or totipotent animal cell, or in vitro cell cultures, embryos, or animals derived therefrom, by maintaining an XY pluripotent or totipotent animal cell in a feminizing medium. Methods and compositions are also provided for maintaining a population of XY pluripotent or totipotent animal cells in a feminizing medium and selecting cells or clones having increased capabilities for producing a fertile female XY animal in an F0 generation. Methods and compositions are also provided for screening for compounds with feminizing activity or for optimizing concentrations of components in feminizing media.
Control profile
Yu P Bai from Flushing, NY, age ~61 Get Report